当前位置：
X-MOL 学术
›
Diabetes Obes. Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study
Diabetes, Obesity and Metabolism ( IF 5.8 ) Pub Date : 2021-07-01 , DOI: 10.1111/dom.14476 Fabrice Bonnet 1 , Hungta Chen 2 , Andrew Cooper 3 , Marίlia B. Gomes 4 , Linong Ji 5 , Paul Leigh 3 , Larisa Ramirez 6 , Marina V. Shestakova 7 , Iichiro Shimomura 8 , Afrah Siddiqui 3 , Fengming Tang 9 , Jiten Vora 10 , Hirotaka Watada 11 , Kamlesh Khunti 12
Diabetes, Obesity and Metabolism ( IF 5.8 ) Pub Date : 2021-07-01 , DOI: 10.1111/dom.14476 Fabrice Bonnet 1 , Hungta Chen 2 , Andrew Cooper 3 , Marίlia B. Gomes 4 , Linong Ji 5 , Paul Leigh 3 , Larisa Ramirez 6 , Marina V. Shestakova 7 , Iichiro Shimomura 8 , Afrah Siddiqui 3 , Fengming Tang 9 , Jiten Vora 10 , Hirotaka Watada 11 , Kamlesh Khunti 12
Affiliation
Glycaemic control is a cornerstone of type 2 diabetes (T2D) management. We assessed factors associated with good long-term glycaemic control in patients with glycated haemoglobin (HbA1c) ≥7.0% at initiation of second-line glucose-lowering therapy, using data from DISCOVER, a global, prospective, 3-year observational study of patients with T2D.
中文翻译：
与开始二线治疗时糖化血红蛋白升高 (≥7.0%) 的 2 型糖尿病患者长期血糖控制相关的因素有哪些？DISCOVER 研究的结果
血糖控制是 2 型糖尿病 (T2D) 管理的基石。我们使用来自 DISCOVER 的数据评估了与糖化血红蛋白 (HbA1c) ≥ 7.0% 的患者在开始二线降糖治疗时长期血糖控制良好相关的因素，DISCOVER 是一项针对患者的全球性前瞻性 3 年观察性研究与 T2D。
更新日期：2021-09-07
中文翻译：
与开始二线治疗时糖化血红蛋白升高 (≥7.0%) 的 2 型糖尿病患者长期血糖控制相关的因素有哪些？DISCOVER 研究的结果
血糖控制是 2 型糖尿病 (T2D) 管理的基石。我们使用来自 DISCOVER 的数据评估了与糖化血红蛋白 (HbA1c) ≥ 7.0% 的患者在开始二线降糖治疗时长期血糖控制良好相关的因素，DISCOVER 是一项针对患者的全球性前瞻性 3 年观察性研究与 T2D。
京公网安备 11010802027423号